Elis shares in Paris have risen by almost 1%, surpassing the market.
This increase follows a recommendation from UBS to 'buy' the shares, with a price target of €27. UBS highlights Elis as a resilient company with strong leadership and promising growth prospects.
The brokerage also mentions that the company's efforts to reduce debt present opportunities for shareholder returns or potential mergers and acquisitions, further enhancing its investment appeal.